Table 1.
Patient demographics and baseline characteristics.
Fig 1.
Comparison of Genedrive® and Taqman assays.
(A) Melt Curve Analysis for detection of SNP and template control. (B) Results of Genedrive assay on initial test samples. (C) Results of Taqman assay on initial test samples. (D) Summary of initial Beta test results in run, remelts, and retests prior to and after assay optimization.
Fig 2.
Clinical study validation of 246 HCV patients.
(A) Workflow and Layout of Assay. (B) Contingency table for sensitivity and specificity to detect CC genotype. (C) Contingency table for sensitivity and specificity to discriminate CC, CT, and TT genotypes.
Table 2.
Summary of clinical test results in runs, remelts, and retests.